"VUB researchers find new virus in patients with chronic fatigue syndrome Researchers at the Free University of Brussels (VUB) and the Belgian biotech company Red Laboratories have succeeded in distinguishing a new retrovirus in patients with chronic fatigue syndrome (CFS / ME patients). Thus they confirm recent U.S. findings on this issue. VUB-Press Service reports that Tuesday.
U.S. researchers at the University of Nevada in October 2009 found that the majority of CFS / ME patients are carriers of a new retrovirus XMRV. These findings have also been confirmed by the Harvard Medical School and the National Institutes of Health (NIH). New to the study led by Professor De Meirleir VUB is that the virus was found in CFS / ME patients from across Europe. Moreover, the immunological signature, a kind of footprint in the immune system, is similar to that of symptomatic HIV patients. "It seems that for the roughly 17 million CFS / ME patients world-wide end to a long ordeal surrounding the recognition of their illness. The development of targeted therapies is already underway, both in Belgium and abroad" says De Meirleir. His new findings on 7 September 8 and presented at a workshop of NIH in Washington."
exciting stuff!
ReplyDeletea google translation of some of it:
"VUB researchers find new virus in patients with chronic fatigue syndrome
Researchers at the Free University of Brussels (VUB) and the Belgian biotech company Red Laboratories have succeeded in distinguishing a new retrovirus in patients with chronic fatigue syndrome (CFS / ME patients). Thus they confirm recent U.S. findings on this issue. VUB-Press Service reports that Tuesday.
U.S. researchers at the University of Nevada in October 2009 found that the majority of CFS / ME patients are carriers of a new retrovirus XMRV. These findings have also been confirmed by the Harvard Medical School and the National Institutes of Health (NIH). New to the study led by Professor De Meirleir VUB is that the virus was found in CFS / ME patients from across Europe. Moreover, the immunological signature, a kind of footprint in the immune system, is similar to that of symptomatic HIV patients. "It seems that for the roughly 17 million CFS / ME patients world-wide end to a long ordeal surrounding the recognition of their illness. The development of targeted therapies is already underway, both in Belgium and abroad" says De Meirleir.
His new findings on 7 September 8 and presented at a workshop of NIH in Washington."